rs574989512
Variant summary
Our verdict is Benign. Variant got -15 ACMG points: 1P and 16B. PP3BP6_Very_StrongBS1BS2
The NM_003482.4(KMT2D):c.5477G>T(p.Gly1826Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000438 in 1,613,920 control chromosomes in the GnomAD database, including 13 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Consequence
NM_003482.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -15 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000375 AC: 57AN: 152164Hom.: 2 Cov.: 32
GnomAD3 exomes AF: 0.000991 AC: 247AN: 249280Hom.: 4 AF XY: 0.00137 AC XY: 185AN XY: 135232
GnomAD4 exome AF: 0.000444 AC: 649AN: 1461638Hom.: 11 Cov.: 32 AF XY: 0.000635 AC XY: 462AN XY: 727108
GnomAD4 genome AF: 0.000381 AC: 58AN: 152282Hom.: 2 Cov.: 32 AF XY: 0.000564 AC XY: 42AN XY: 74468
ClinVar
Submissions by phenotype
not specified Benign:2Other:1
- -
The KMT2D p.Gly1826Val variant was not identified in the literature but was identified in dbSNP (ID: rs574989512) and ClinVar (classified as benign by EGL Genetics). The variant was identified in control databases in 250 of 280666 chromosomes (4 homozygous) at a frequency of 0.0008907 increasing the likelihood this could be a low frequency benign variant (Genome Aggregation Database March 6, 2019, v2.1.1). The variant was observed in the following populations: South Asian in 243 of 30602 chromosomes (freq: 0.007941), Other in 6 of 7144 chromosomes (freq: 0.00084) and African in 1 of 24188 chromosomes (freq: 0.000041), but was not observed in the Latino, Ashkenazi Jewish, East Asian, European (Finnish), or European (non-Finnish) populations. The p.Gly1826 residue is conserved in mammals and computational analyses (PolyPhen-2, SIFT, AlignGVGD, BLOSUM, MutationTaster) provide inconsistent predictions regarding the impact to the protein; this information is not very predictive of pathogenicity. The variant occurs outside of the splicing consensus sequence and in silico or computational prediction software programs (SpliceSiteFinder, MaxEntScan, NNSPLICE, GeneSplicer) do not predict a difference in splicing. In summary, based on the above information this variant meets our laboratory's criteria to be classified as benign. -
- -
not provided Benign:2
- -
This variant is associated with the following publications: (PMID: 30459467) -
Kabuki syndrome Benign:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at